Parkinsonism in patients with a history of amphetamine exposure. - Wikidata - awgldk - TriplyDB

Parkinsonism in patients with a history of amphetamine exposure.

Parkinsonism in patients with a history of amphetamine exposure.

http://www.wikidata.org/entity/Q33698983

about

Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis Neurologic manifestations of chronic methamphetamine abuse Monoamine reuptake inhibitors in Parkinson's disease.Neurologic manifestations of chronic methamphetamine abuse.Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons.MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex

P2860

Q23914214-79A3C621-BD70-4A6B-8CCC-80421CE72B6C Q24624506-FC5D965B-CF36-4EBE-B81B-C7FACE576B70 Q35165280-343879CB-48F9-4D40-BA26-3B1CAA460E54 Q37150547-47D3440F-B680-4990-AF69-F20B0FCAC142 Q38100688-6D6F8E8E-C647-4A21-ADA8-CF6CE6EE5315 Q42446212-85AB7CDD-3EA5-41BE-A09A-0790E58338A3 Q46429572-2817436E-8AA7-4CCF-A21C-D9DEBB9E5BE7 Q52148359-C08937F7-0FFE-4922-B6A5-D69AFDB7F1D1 Q53175834-FC3B88F6-DC2B-470F-8554-79E59963E3CD Q57778958-796F4C86-B071-4E3D-99C4-C87A5C119A79

P2860

Parkinsonism in patients with a history of amphetamine exposure.

http://www.wikidata.org/entity/Q33698983

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Parkinsonism in patients with a history of amphetamine exposure.

@ast

Parkinsonism in patients with a history of amphetamine exposure.

@en

type

label

Parkinsonism in patients with a history of amphetamine exposure.

@ast

Parkinsonism in patients with a history of amphetamine exposure.

@en

prefLabel

Parkinsonism in patients with a history of amphetamine exposure.

@ast

Parkinsonism in patients with a history of amphetamine exposure.

@en

P1433

Q33698983-A686FECF-ADA7-4F1F-A98C-A2450770290F

P1476

Q33698983-448A4F85-18B8-473A-A162-94D6D765E539

P2093

Q33698983-19A68B48-2836-45CC-887C-73839DAB396F

Q33698983-4919C3FA-9641-49AE-8614-340306F30CA3

Q33698983-4D94230A-94AA-401D-B6A6-04B2547106DB

Q33698983-99B64DCD-502D-474B-996F-3FF2E2A8A9F4

Q33698983-CC85BC70-683E-4BF6-9B8E-E611A04FD5A4

P2860

Q33698983-12ADC55F-FD91-4EB5-8722-3ADF738B6EEC

Q33698983-1A7C2B49-8825-4B68-B5B4-7A5BC7CF512F

Q33698983-29FDE8F7-E4C5-4103-A40F-9EA39D8C99E2

Q33698983-366162ED-DF85-4C5C-BE9E-2D930FAC6EF3

Q33698983-5C44A895-C315-4FC2-81A1-31052694F126

Q33698983-6C164E3A-5E03-4A99-9A00-B6128ACF054C

Q33698983-6D811C98-6F52-4541-8EC0-81375B22A417

Q33698983-738AA52F-715F-4C91-85D6-B2870DB59D23

Q33698983-8171D720-24CF-4B2E-B7C9-3D14F829BE54

Q33698983-B81CF0E5-D5D3-4D99-B69E-0399EE9DCDA1

P304

Q33698983-B262750B-7962-4186-86A8-B2E3015E4AE1

P31

Q33698983-DA955DA7-6DD2-4633-B06F-5304ACFFFEB2

P356

Q33698983-1EAB7D1C-3840-45BD-B3A3-12DEAAEB8A7D

P407

Q33698983-CA45C5C1-1D53-492D-BEAD-FA38F1750438

P433

Q33698983-F21308CF-4E6C-4FD9-B0F2-DB20A055D155

P478

Q33698983-FF3A3399-0DE6-48B7-8FEF-67A13C8ACBFF

P577

Q33698983-C8BB168D-576B-4735-85C9-EB5D0A4E817C

P5875

Q33698983-BAA94AC5-5E51-4675-AEB8-D05AAED1DA18

P698

Q33698983-3EA5CCE3-B4F2-482A-A851-2F3AA6BCF32C

P921

Q33698983-201362B9-528D-4C4A-8DDF-B5F280177710

P932

Q33698983-7BE207CF-6661-4974-9897-A22F780E8F2D

P356

P1433

Movement Disorders

P1476

Parkinsonism in patients with a history of amphetamine exposure.

@en

P2093

Chadwick W Christine

http://www.w3.org/2001/XMLSchema#string

Charles E McCulloch

http://www.w3.org/2001/XMLSchema#string

Daniel E Austin

http://www.w3.org/2001/XMLSchema#string

Elisabeth R Garwood

http://www.w3.org/2001/XMLSchema#string

Lauren E Schrock

http://www.w3.org/2001/XMLSchema#string

P2860

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates.

Diagnostic criteria for Parkinson disease.

Is methamphetamine abuse a risk factor in parkinsonism?

Nongenetic causes of Parkinson's disease.

Update on the genetics of Parkinson's disease.

Update in the epidemiology of Parkinson's disease.

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

A Parkinsonian syndrome in methcathinone users and the role of manganese.

Why is parkinsonism not a feature of human methamphetamine users?

P304

228-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.22915

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40901098

http://www.w3.org/2001/XMLSchema#string

P698

20063432

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2831101

http://www.w3.org/2001/XMLSchema#string